Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - Artemis Therapeutics, Inc. | zk1618738.htm |
| EX-31.2 - EXHIBIT 31.2 - Artemis Therapeutics, Inc. | exhibit_31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Artemis Therapeutics, Inc. | exhibit_31-1.htm |
EXHIBIT 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICERS
PURSUANT TO U.S.C. SEC. 1350
Each of the undersigned officers of New York Global Innovations Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge:
| (i) | That the Quarterly Report for the fiscal quarter ended June 30, 2016 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (ii) | The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
Date: July 21, 2016
|
/s/ Gadi Peleg
|
||
|
By: Gadi Peleg, Chairman of the Board
(Principal Executive Officer)
|
|||
|
Date: July 21, 2016
|
/s/ Chanan Morris
|
||
|
By: Chanan Morris, Chief Financial Officer
(Principal Financial and Accounting Officer)
|
|||